Breakthrough Cancer Research At Cork Laboratory

Published: Feb. 13, 2022, 1 p.m.

Breakthrough Cancer Research (Breakthrough), University College Cork (UCC) and Cork University Hospital (CUH) are thrilled to announce exciting new cancer research that has unlocked why some cancers are drug resistant, which has led to a novel chemotherapy treatment incorporating Lithium. Orla Dolan, CEO of Breakthrough Cancer Research, the leading cancer research charity in Ireland for poor prognosis cancers, said, \u201cResistance to chemotherapy is a major challenge for clinicians and devastating for patients. This discovery was fuelled by collaboration between researchers in the lab and doctors in the hospital working to overcome clinical challenges.\xa0 This is a wonderful example of how patient focused research supported by the generosity of the public can translate from the lab into new treatments in the clinic.\u201d Consultant Oncologist Professor Seamus O\u2019Reilly, based at Cork University Hospital and Mercy University Hospital, was so inspired by the results that he agreed to lead the clinical trials, as he knows only too well the value and lifesaving potential of a breakthrough like this.